Donald P. Newman
Donald P. Newman's purchase track record
Donald P. Newman has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/18/2024 | ASIX | $149K | +2.4% | -16.8% | +1.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
JP Morgan cuts Amrize price target to $48, maintains Neutral. JP Morgan has lowered its price target for Amrize to $48 while keeping a Neutral rating. This move comes as the company prepares to announce its third-quarter 2026 financial results. Recent reports also highlight the firm's regional scale and pricing power, though the current analyst target sits below the average consensus of $47.20.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
ATI Announces Q3 2026 Webcast, Appears in Growth Stock Picks. Recent articles have placed ATI among several growth‑stock recommendations for mid‑October. The company will host a webcast to present its third‑quarter 2026 results, and analysts are questioning whether it will meet earnings estimates again. Commentators also note ATI’s strong cash flow and cite potential upside, while the stock slipped about 1% in recent trading. The shares are currently near a long‑standing support level.
Transaction History
| ASIX | ▲ Buy | Grant | 6,207 | $0 | 6/22/2026 | View on chart |
| AMRZ | ▲ Buy | Grant | 2,976 | $0 | 4/21/2026 | View on chart |
| ASIX | ▲ Buy | Grant | 1,721 | $27K | 12/15/2025 | View on chart |
| ASIX | ▲ Buy | Grant | 1,418 | $27K | 9/30/2025 | View on chart |
| ASIX | ▲ Buy | Grant | 977 | $23K | 6/30/2025 | View on chart |
| ASIX | ▲ Buy | Grant | 5,020 | $0 | 6/18/2025 | View on chart |
| ASIX | ▲ Buy | Grant | 993 | $22K | 3/31/2025 | View on chart |
| ATI | ▼ Sell | Tax Withholding | 4,139 | $234K | 1/6/2025 | View on chart |
| ATI | ▲ Buy | Grant | 94,650 | $0 | 1/6/2025 | View on chart |
| ATI | ▼ Sell | Tax Withholding | 37,245 | $2.1M | 1/6/2025 | View on chart |
| ATI | ▲ Buy | Grant | 8,300 | $0 | 1/3/2025 | View on chart |
| ATI | ▼ Sell | Tax Withholding | 3,352 | $187K | 1/3/2025 | View on chart |
| ASIX | ▲ Buy | Open Market | 5,030 | $149K | 11/18/2024 | View on chart |
| ATI | ▲ Buy | Grant | 90,953 | $0 | 1/9/2024 | View on chart |
| ATI | ▼ Sell | Tax Withholding | 37,012 | $1.6M | 1/9/2024 | View on chart |
| ATI | ▼ Sell | Tax Withholding | 10,355 | $451K | 1/4/2024 | View on chart |
| ATI | ▼ Sell | Tax Withholding | 2,016 | $87K | 1/3/2024 | View on chart |
| ATI | ▲ Buy | Grant | 10,423 | $0 | 1/3/2024 | View on chart |
| ATI | ▼ Sell | Tax Withholding | 2,542 | $100K | 2/24/2023 | View on chart |
| ATI | ▲ Buy | Grant | 13,214 | $0 | 2/23/2023 | View on chart |
| ATI | ▼ Sell | Tax Withholding | 5,534 | $224K | 2/23/2023 | View on chart |
| ATI | ▼ Sell | Tax Withholding | 6,459 | $196K | 1/4/2023 | View on chart |
| ATI | ▼ Sell | Tax Withholding | 4,139 | $126K | 1/4/2023 | View on chart |
| ATI | ▲ Buy | Grant | 14,066 | $0 | 1/3/2023 | View on chart |
| ATI | ▼ Sell | Tax Withholding | 2,761 | $65K | 2/24/2022 | View on chart |
| ATI | ▼ Sell | Tax Withholding | 3,740 | $65K | 1/6/2022 | View on chart |
| ATI | ▼ Sell | Tax Withholding | 7,384 | $124K | 1/4/2022 | View on chart |
| ATI | ▲ Buy | Grant | 31,550 | $0 | 1/4/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
AdvanSix Featured in Chemical Stocks With Natural Gas Cost Edge
AdvanSix (ASIX) was included in a recent article highlighting three US chemical stocks that benefit from lower natural gas costs. This cost advantage is relevant to the company's production expenses in the specialty chemicals sector. The stock is currently trading below its average analyst target price, with a 52-week range extending from $14.10 to $26.73.
AdvanSix Featured in Chemical Stocks With Natural Gas Cost Edge. AdvanSix (ASIX) was included in a recent article highlighting three US chemical stocks that benefit from lower natural gas costs. This cost advantage is relevant to the company's production expenses in the specialty chemicals sector. The stock is currently trading below its average analyst target price, with a 52-week range extending from $14.10 to $26.73.